BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8402464)

  • 1. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder.
    Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility.
    Sørensen FB; Sasaki M; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Lab Invest; 1994 Feb; 70(2):242-54. PubMed ID: 8139265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact.
    Sørensen FB; Bichel P; Jakobsen A
    Cancer; 1992 Jan; 69(1):187-99. PubMed ID: 1727663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts.
    Ladekarl M
    Cancer; 1995 Apr; 75(8):2114-22. PubMed ID: 7697602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast.
    Ladekarl M; Sørensen FB
    Cancer; 1993 Nov; 72(9):2602-11. PubMed ID: 8402482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereological estimation of nuclear volume and other quantitative histopathological parameters in the prognostic evaluation of supraglottic laryngeal squamous cell carcinoma.
    Sørensen FB; Bennedbaek O; Pilgaard J; Spaun E
    APMIS; 1989 Nov; 97(11):987-95. PubMed ID: 2686723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast.
    Ladekarl M; Sørensen FB
    APMIS; 1993 Dec; 101(12):895-903. PubMed ID: 8110444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
    J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
    Ladekarl M
    APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereological estimates of nuclear volume in the prognostic evaluation of primary flat carcinoma in situ of the urinary bladder.
    Sørensen FB; Jacobsen F
    Histopathology; 1991 Jun; 18(6):531-9. PubMed ID: 1879813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period.
    Sørensen FB
    Cancer; 1989 May; 63(9):1784-98. PubMed ID: 2702586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors.
    Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Smeets AW; Pauwels RP
    Cancer; 2000 Jun; 88(11):2598-605. PubMed ID: 10861439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer.
    Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Sasaki M; Takeuchi H; Okabe T
    Int J Urol; 2003 Mar; 10(3):149-52. PubMed ID: 12622711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading of superficial bladder cancer by quantitative mitotic frequency analysis.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    J Urol; 1993 Jan; 149(1):36-41. PubMed ID: 8417213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereologic estimates of nuclear volume in noninvasive bladder tumors (Ta) correlated with the recurrence pattern.
    Nielsen K; Orntoft T; Wolf H
    Cancer; 1989 Dec; 64(11):2269-74. PubMed ID: 2804918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R
    Eur J Cancer; 1992; 29A(1):69-75. PubMed ID: 1445749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.